Alessandro Reto Caviezel

Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: medium-term follow-up

Objective. Minimally invasive treatment of small kidney tumours remains a challenge. Cryoablation has recently been advocated for such neoplasias. However, few series evaluating this therapeutic regimen are as yet available. The goal of this retrospective study was to evaluate the initial clinical experience of magnetic resonance imaging (MRI)-guided percutaneous cryotherapy of small renal tumours. Material and methods. Seven patients with small renal tumours [mean diameter 21 (11–30) mm] underwent percutaneous renal tumour cryoablation using the Cryo-Hit® delivery system. The procedure was performed in an MRI interventional unit, using a 0.23 Tesla open MRI imaging system. Five men and two women were included in the group. The average age was 61.5 (34–84) years. The patients had a solitary kidney (n=2), renal insufficiency (n=4) or a kidney graft (n=1). The intervention was performed under general anaesthesia. Average time for the whole procedure was 235 min with 26 min of effective treatment time. Mean follow-up was 28 (7–43) months. Results. All tumours were successfully ablated. There were no perioperative complications. Mean hospital stay was 2.4 (2–5) days. One patient stayed for 5 days because therapeutic anticoagulation had to be reinitiated. No significant change in the perioperative value of the serum creatinine was noticed. No radiographic evidence of disease recurrence or new tumour development was identified during the follow-up. Conclusions. In this small group of patients, percutaneous renal tumour cryoablation under MRI guidance was efficient and carried no morbidity. Hospital stay was remarkably shorter than that of surgically treated patients. At medium-term follow-up, no recurrence has been identified, but long-term follow-up is required.

Female hydrocele: the cyst of Nuck

The canal of Nuck is the portion of the processus vaginalis within the inguinal canal in women. A hydrocele of the canal of Nuck is equivalent to an encysted hydrocele of the cord in men. The literature reveals very little about this rare condition in the adult female patient. In this paper, we report a case of hydrocele of the canal of Nuck in a young female. The diagnosis was made with ultrasound and magnetic resonance imaging and then confirmed preoperatively and by histopathology. Although rare, a hydrocele of the canal of Nuck has to be included in the differential diagnosis of a groin lump in female patients.

Novel injectable urethral bulking agents for the treatment of urinary incontinence.

Stress urinary incontinence is a highly prevalent disorder resulting from weak urethral closure mechanisms. Endoscopic injection of a urethral bulking agent (UBA) under the urethral mucosa increases coaptation, which improves continence. Collagen is an efficient agent, although its effects are limited in time. Other materials still suffer either from a short-lasting effect or migration in distant organs. We evaluated here novel UBAs using an ex vivo model, with respect to criteria of ease of injection, ability to form a high and stable tissue bulking, implant elasticity and tissue reaction. One approach involves solutions of polymers in water-miscible organic solvents that precipitates in situ. In this manner, high and stable bulks were routinely obtained using various commercial polymers. Selected solvents reduced the tissue reaction to the implant. Microsphere suspensions in hydrogels also proved to be efficient UBA, although less stable bulks were obtained. Thermosetting chitosan hydrogels showed promising results with respect to bulk stability and isoelasticity with surrounding tissues. Different strategies have thus been compared and optimised ex vivo. Further experiments are required to compare the ability of these materials to induce a sustained in vivo bulking effect.

A New MDCT Technique for the Detection and Anatomical Exploration of Urogenital Fistulas

OBJECTIVE We tested a new MDCT technical protocol, combining i.v. and intravesical positive contrast agent and intravaginal neutral contrast agent, that optimizes exploration of urogenital fistulas. We examined three patients (four CT examinations in total) with this technique and proved that a preexisting subtle ureterovaginal fistula that was under treatment was still present, though clinically silent. CONCLUSION The proposed MDCT examination protocol provides important information to help detect subtle urogenital fistulas.

[Robot-assisted surgery in urology].

Since 1990, laparoscopic surgery has undergone a tremendous evolution. As patients and surgeons alike push toward minimally invasive surgery, more and more complex operations have been performed by laparoscopy. However, highly complex and technically demanding procedures--such as radical prostatectomy--have revealed the limits of classical laparoscopic surgery. The introduction of the Da Vinci robot has changed the face of modern laparoscopy because it provides the surgeon with three-dimensional vision, more instrumental degrees of freedom, and greater ergonomics. Thus, laparoscopy has been able to strengthen its role in urology and is increasingly being used for radical prostatectomies, pyeloplasties, and ureteral operations such as ureterovesical reimplantations. For most types of operations, functional and early oncological outcomes appear similar to those of conventional laparoscopy or open surgery. The main drawbacks of robotic surgery are the costs of the disposable instruments and maintenance, which overshadow the initial purchase price. The near future will show how European health systems will react to this new financial burden. Our institution, within a university hospital with moderate patient recruitment, was equipped with a four-arm Da Vinci robot in February 2006. As of April 2008, 120 urological operations had been performed. Because robotic surgery is associated with a specific learning curve, divisions with limited case numbers may refrain from doing this type of surgery. The aim of this article is to evaluate the feasibility and efficiency of the initial period of a robotic program in a midsize division.

Roboterassistierte Operationen in der Urologie

Since 1990, laparoscopic surgery has undergone a tremendous evolution. As patients and surgeons alike push toward minimally invasive surgery, more and more complex operations have been performed by laparoscopy. However, highly complex and technically demanding procedures--such as radical prostatectomy--have revealed the limits of classical laparoscopic surgery. The introduction of the Da Vinci robot has changed the face of modern laparoscopy because it provides the surgeon with three-dimensional vision, more instrumental degrees of freedom, and greater ergonomics. Thus, laparoscopy has been able to strengthen its role in urology and is increasingly being used for radical prostatectomies, pyeloplasties, and ureteral operations such as ureterovesical reimplantations. For most types of operations, functional and early oncological outcomes appear similar to those of conventional laparoscopy or open surgery. The main drawbacks of robotic surgery are the costs of the disposable instruments and maintenance, which overshadow the initial purchase price. The near future will show how European health systems will react to this new financial burden. Our institution, within a university hospital with moderate patient recruitment, was equipped with a four-arm Da Vinci robot in February 2006. As of April 2008, 120 urological operations had been performed. Because robotic surgery is associated with a specific learning curve, divisions with limited case numbers may refrain from doing this type of surgery. The aim of this article is to evaluate the feasibility and efficiency of the initial period of a robotic program in a midsize division.

Roboterassistierte Operationen in der Urologie@@@Robot-assisted surgery in urology

Since 1990, laparoscopic surgery has undergone a tremendous evolution. As patients and surgeons alike push toward minimally invasive surgery, more and more complex operations have been performed by laparoscopy. However, highly complex and technically demanding procedures--such as radical prostatectomy--have revealed the limits of classical laparoscopic surgery. The introduction of the Da Vinci robot has changed the face of modern laparoscopy because it provides the surgeon with three-dimensional vision, more instrumental degrees of freedom, and greater ergonomics. Thus, laparoscopy has been able to strengthen its role in urology and is increasingly being used for radical prostatectomies, pyeloplasties, and ureteral operations such as ureterovesical reimplantations. For most types of operations, functional and early oncological outcomes appear similar to those of conventional laparoscopy or open surgery. The main drawbacks of robotic surgery are the costs of the disposable instruments and maintenance, which overshadow the initial purchase price. The near future will show how European health systems will react to this new financial burden. Our institution, within a university hospital with moderate patient recruitment, was equipped with a four-arm Da Vinci robot in February 2006. As of April 2008, 120 urological operations had been performed. Because robotic surgery is associated with a specific learning curve, divisions with limited case numbers may refrain from doing this type of surgery. The aim of this article is to evaluate the feasibility and efficiency of the initial period of a robotic program in a midsize division.